ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,842.63
      1.12%
      US Tech 100
      20,043.20
      1.12%
      Dow Jones
      43,006.59
      1.14%
      Brent Oil
      69.665
      0.58%
      Bitcoin
      91,672.16
      1.15%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cue Biopharma Inc (CUE) Quote

      Cue Biopharma Inc

      Cue Biopharma Inc (CUE)

      Cue Energy Resources Limited
      1.12
      -0.05
      (-4.27%)
      Closed March 05 4:00PM
      Delayed by 15 minutes
      1.11
      -0.01
      (-0.89%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.12
      Bid
      1.05
      Ask
      1.12
      Volume
      296,184
      1.08 Day's Range 1.17
      0.45 52 Week Range 2.26
      Market Cap
      70.952M
      Previous Close
      1.17
      Open
      1.16
      Last Trade
      1
      @
      1.08
      Last Trade Time
      Financial Volume
      $ 333,781
      VWAP
      1.1269
      Average Volume (3m)
      293,780
      Shares Outstanding
      63,350,327
      Dividend Yield
      -
      PE Ratio
      -1.39
      Earnings Per Share (EPS)
      -0.8
      Revenue
      5.49M
      Net Profit
      -50.73M

      About Cue Biopharma Inc

      Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.cuebiopharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CUE. The last closing price for Cue Biopharma was $1.17. Over the last year, Cue Biopharma shares have traded in a share price range of $ 0.45 to $ 2.26.

      Cue Biopharma currently has 63,350,327 shares outstanding. The market capitalization of Cue Biopharma is $74.12 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.39.

      Ask ADVFN Intelligence (AI)

      CUE Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 03 2025
      CUE (-4.27%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 03 2025
      CUE (-4.27%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 29 2024
      CUE (-4.27%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      November 29 2024
      CUE (-4.27%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 14 2024
      CUE (-4.27%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 14 2024
      CUE (-4.27%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.11-8.943089430891.231.331.072162811.21519145CS
      4-0.3-21.12676056341.421.541.071789321.30350795CS
      120.010.9009009009011.111.750.922937801.27562905CS
      260.45568.42105263160.6651.98910.455378771.25648153CS
      52-0.94-45.63106796122.062.260.454362881.2748357CS
      156-3.93-77.82178217825.056.290.453471132.53911525CS
      260-20.27-94.763908368421.3935.50.453397727.3538486CS

      CUE - Frequently Asked Questions (FAQ)

      What is the current Cue Biopharma share price?
      The current share price of Cue Biopharma is $ 1.12
      How many Cue Biopharma shares are in issue?
      Cue Biopharma has 63,350,327 shares in issue
      What is the market cap of Cue Biopharma?
      The market capitalisation of Cue Biopharma is USD 74.12M
      What is the 1 year trading range for Cue Biopharma share price?
      Cue Biopharma has traded in the range of $ 0.45 to $ 2.26 during the past year
      What is the PE ratio of Cue Biopharma?
      The price to earnings ratio of Cue Biopharma is -1.39
      What is the cash to sales ratio of Cue Biopharma?
      The cash to sales ratio of Cue Biopharma is 12.8
      What is the reporting currency for Cue Biopharma?
      Cue Biopharma reports financial results in USD
      What is the latest annual turnover for Cue Biopharma?
      The latest annual turnover of Cue Biopharma is USD 5.49M
      What is the latest annual profit for Cue Biopharma?
      The latest annual profit of Cue Biopharma is USD -50.73M
      What is the registered address of Cue Biopharma?
      The registered address for Cue Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Cue Biopharma website address?
      The website address for Cue Biopharma is www.cuebiopharma.com
      Which industry sector does Cue Biopharma operate in?
      Cue Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GVVisionary Holdings Inc
      $ 3.6999
      (186.81%)
      		188.04M
      CMRXChimerix Inc
      $ 8.435
      (70.06%)
      		118.56M
      ARBBARB IOT Group Ltd
      $ 0.8262
      (58.88%)
      		87.92M
      CDXCChromaDex Corporation
      $ 8.5507
      (52.69%)
      		18.71M
      SOBRSOBR Safe Inc
      $ 0.6602
      (41.04%)
      		10.67M
      CUTRCutera Inc
      $ 0.1209
      (-61.55%)
      		23.22M
      XCURExicure Inc
      $ 9.92
      (-30.53%)
      		133.38k
      STBXStarBox Group Holdings Ltd
      $ 0.3481
      (-29.20%)
      		2.7M
      LBGJLi Bang International Corporation Inc
      $ 1.50
      (-25.00%)
      		269.2k
      SMSTDefiance Daily Target 2x Short MSTR ETF
      $ 4.7255
      (-24.75%)
      		29.42M
      NVDANVIDIA Corporation
      $ 117.30
      (1.13%)
      		284.33M
      GVVisionary Holdings Inc
      $ 3.6999
      (186.81%)
      		188.04M
      ADTXAditxt Inc
      $ 0.0592
      (18.88%)
      		160.54M
      INTCIntel Corporation
      $ 20.81
      (-2.44%)
      		127.21M
      CMRXChimerix Inc
      $ 8.435
      (70.06%)
      		118.56M

      CUE Discussion

      View Posts
      boston127 boston127 2 months ago
      Send URL for the funds loading info.

      I also bought today and last week, but am RED because I bought at a higher price.
      👍️0
      Hawkeye_tt Hawkeye_tt 2 months ago
      You can easily see when a Fund is loading for the day.
      I backed up the truck in the 50 cent dip area. That was a gift.
      GL all.....be patient.

      Hawk
      👍️0
      boston127 boston127 2 months ago
      Today's volume was heavier than usual,

      trading 1,209,308 shares, versus an average of 459,032 shares per day during the last twelve months. The On Balance Volume indicator (OBV) shows that longer term selling pressure has given way to near term accumulation by traders.
      👍️0
      boston127 boston127 2 months ago
      Momentum for CUE is strongly bullish.

      The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. Good day today. Got back in recently. Will continue adding all the way to $3.
      👍️0
      boston127 boston127 2 months ago
      Thanks. Interesting perspective.

      As long as the company is doing well, I can wait and suffer through any dips.
      👍️0
      Hawkeye_tt Hawkeye_tt 2 months ago
      This could be Over $5 right now...IMO. Algos/shorts walked this down for mths.
      LT looks very good IMO.

      Hawk
      👍️0
      boston127 boston127 2 months ago
      Great day on Friday.

      Wondering if profit taking will follow suit this week.
      👍️0
      Hawkeye_tt Hawkeye_tt 2 months ago
      2025 should be a very good yr. New Partnerships and more.

      Hawk
      👍️0
      glenn1919 glenn1919 2 months ago
      cue.........................https://stockcharts.com/h-sc/ui?s=cue&p=W&b=5&g=0&id=p86431144783
      👍️0
      Hawkeye_tt Hawkeye_tt 5 months ago
      TY for that quick dip/Algo dump op. Took advantage big time.
      GL all...

      Hawk
      👍️0
      boston127 boston127 5 months ago
      Momentum for CUE is waning,

      as measured by a 14-period Slow Stochastic Oscillator. This means that investors are less aggressive in their recent purchases and may even be taking profits in positions bought at lower prices.
      👍️0
      boston127 boston127 5 months ago
      The On Balance Volume indicator (OBV) is bullish.

      The slope of the indicator is positive and suggests that buyers are presently more active than sellers.Today's volume was heavier than usual, trading 2,320,021 shares, versus an average of 389,835 shares per day during the last twelve months.
      👍️0
      boston127 boston127 5 months ago
      Momentum for CUE is strongly bullish.

      The 14-period Slow Stochastic oscillator is above 80, the level which many analysts call overbought. This means that investors have been actively purchasing shares and driving the price higher.
      👍️0
      boston127 boston127 5 months ago
      I got in on Friday. Everything

      about the company is good. Gotta love it. They did not give up much to get that $11M in financing. Will buy on dips. Bought a little more today.
      👍️0
      Monksdream Monksdream 5 months ago
      CUE under $2
      👍️0
      Hawkeye_tt Hawkeye_tt 5 months ago
      Look at that Wkly candle ! Vol fantastic.
      LT outlook back on !

      Hawk
      👍️0
      Triple nickle Triple nickle 5 months ago
      CUE ready to win 1.02
      👍️0
      Hawkeye_tt Hawkeye_tt 5 months ago
      Strong recovery on news....future looking good here. Buy, hold LT...
      Hawk
      👍️0
      Monksdream Monksdream 8 months ago
      CUE new 52 week low
      👍️0
      Hawkeye_tt Hawkeye_tt 2 years ago
      CUE....this story grows quickly. Merck early investor.
      Last few wks it has been breaking out.
      $5 break next. More Partners want in, on top of Ono.

      Hawk
      👍️0
      conix conix 3 years ago
      CUE Insider Buy
      Cue Biopharma Aaron G.L. Fletcher Director Buy 735,000 shares @ $4.76 $3,498,600.00 3/31/2022
      👍️0

      Your Recent History

      NASDAQ
      CUE
      Cue Biopharma
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads